SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

SOFINNOVA VENTURE PARTNERS VI L P

(Last)

(First)

(Middle)

140 GEARY STREET, 10TH FLOOR

(Street)

SAN FRANCISCO

94108

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Anthera Pharmaceuticals Inc [ ANTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2010

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/04/2010		C		384,175	A	⁽¹⁾	384,175	D⁽²⁾
Common Stock	03/04/2010		C		828,323	A	⁽³⁾	1,212,498	D⁽²⁾
Common Stock	03/04/2010		C		864,855	A	⁽⁴⁾	2,077,353	D⁽²⁾
Common Stock	03/04/2010		C⁽⁸⁾		236,032	A	$5.25	2,313,385	D⁽²⁾
Common Stock	03/04/2010		C⁽⁸⁾		350,056	A	$5.25	2,663,441	D⁽²⁾
Common Stock	03/04/2010		C⁽⁸⁾		155,127	A	$6.58	2,818,568	D⁽²⁾
Common Stock	03/04/2010		A		744,496	A	$6.58	3,563,064	D⁽²⁾
Common Stock	03/04/2010		A		420,166	A	$7	3,983,230	D⁽²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Series A-2 Convertible Preferred Stock	⁽¹⁾	03/04/2010		C			384,175	⁽¹⁾	⁽⁵⁾	Common Stock	384,175	⁽¹⁾	0	D⁽²⁾
Series B-1 Convertible Preferred Stock	⁽³⁾	03/04/2010		C			828,323	⁽³⁾	⁽⁵⁾	Common Stock	828,323	⁽³⁾	0	D⁽²⁾
Series B-2 Convertible Preferred Stock	⁽⁴⁾	03/04/2010		C			864,855	⁽⁴⁾	⁽⁵⁾	Common Stock	864,855	⁽⁴⁾	0	D⁽²⁾
Stock Purchase Warrant	$7	03/04/2010		A		42,167		⁽⁶⁾	07/17/2014	Common Stock	42,167	$0	42,167	D⁽²⁾
Stock Purchase Warrant	$7	03/04/2010		A		63,251		⁽⁷⁾	09/09/2014	Common Stock	63,251	$0	63,251	D⁽²⁾

Explanation of Responses:

1. Each share of Series A-2 Convertible Preferred Stock was automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.

2. Shares are held by Sofinnova Venture Partners VI, L.P. ("SV VI"). Sofinnova Management VI, L.L.C. ("SV VI LLC") is the general partner of SV VI, and James I. Healy, a director of the issuer, Michael F. Powell, Alain L. Azan and Eric P. Buatois, the managing members of SV VI LLC, may be deemed to share voting and dispositive power over the shares held by SV VI. Such persons and entities disclaim beneficial ownership of shares held by SV VI except to the extent of any pecuniary interest therein.

3. Each share of Series B-1 Convertible Preferred Stock was automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.

4. Each share of Series B-2 Convertible Preferred Stock was automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.

5. The Series A-2, Series B-1 and Series B-2 Convertible Preferred Stock have no expiration date.

6. The warrants were issued on July 17, 2009 and are immediately exercisable, subject to the satisfaction of certain conditions.

7. The warrants were issued on September 9, 2009 and are immediately exercisable, subject to the satisfaction of certain conditions.

8. The Common Stock was acquired upon conversion of a Senior Secured Convertible Promissory Note exempt from the definition of a derivative security and whose conversion ratio did not become fixed until automatic conversion at the time of the closing of the Issuer's initial public offering.

	SOFINNOVA VENTURE PARTNERS VI, L.P., By Sofinnova Management VI, L.L.C.	03/08/2010
	By: Nathalie Auber, Attorney-in-Fact for James I. Healy, M.D., Ph.D., Managing Member	03/08/2010
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.